A newly developed radiolabeled antibody that targets the cancer antigen IL13Rα2 has been found to be highly specific, binding ...

Eli Lilly has signed a new research deal with BigHat Biosciences to co-develop next-generation antibody therapeutics, as the ...

Swiss oncology firm Veraxa Biotech is set to go public in the US through a merger with Voyager Acquisition Corp, a healthcare ...

Epsilogen has acquired antibody developer TigaTx in a deal that collates work from the companies’ alternative antibody isotopes for cancer.

A phase 3 trial involving nearly 25,000 older adults across 17 countries found that a single dose of the RSVPreF3 OA vaccine ...

4 The technique, which images samples at a 10 nanometer-resolution in two dimensions (2D), uses a single-stranded DNA attached to an antibody that binds to a cellular target. A fluorescently-labeled ...

The Centers for Disease Control and Prevention might soon limit its guidance for who should receive a coronavirus booster ...

A 43-year-old woman presented with 6 months of recurrent bilateral eye pain and redness alongside spontaneous urticaria.She ...

The 1950s was a turning point for polio. Amid deadly outbreaks, Jonas Salk developed a vaccine that saved countless lives ...

President Donald Trump on Friday underwent his annual physical at Walter Reed National Military Medical Center, marking his ...